Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inderjit

Showing results (571-580 of 605) with videos related to

Pageof 61
Sort By:
Pulmonary Circulation|January 26, 2026
Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task ForceAaron B Waxman, Abraham Babu, Roberto Badagliacca, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
The Oncologist|November 19, 2024
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanomaJeffrey Weber, Waqas Haque, Svetomir N Markovic, et al.
JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With <i>BRAF</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.
Frontiers in Oncology|December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumorsDavid Gill, Charles L Cowey, Gregory A Daniels, et al.
Techniques in Coloproctology|July 30, 2025
The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)H K Sekhon Inderjit Singh, P Meinero, F C Campanile, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Proximal Pulmonary Artery Stiffening as a Biomarker of Cardiopulmonary AgingRuben De Man, Zhongyu Cai, Pramath Doddaballapur, et al.
Aob PLANTS|October 23, 2019
Drivers of the relative richness of naturalized and invasive plant species on EarthFranz Essl, Wayne Dawson, Holger Kreft, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
Cancer|August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b studyMohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
Pageof 61

Showing results (571-580 of 605) with videos related to

Sort By:
Pageof 61
Pulmonary Circulation|January 26, 2026
Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task ForceAaron B Waxman, Abraham Babu, Roberto Badagliacca, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
The Oncologist|November 19, 2024
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanomaJeffrey Weber, Waqas Haque, Svetomir N Markovic, et al.
JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With <i>BRAF</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.
Frontiers in Oncology|December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumorsDavid Gill, Charles L Cowey, Gregory A Daniels, et al.
Techniques in Coloproctology|July 30, 2025
The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)H K Sekhon Inderjit Singh, P Meinero, F C Campanile, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Proximal Pulmonary Artery Stiffening as a Biomarker of Cardiopulmonary AgingRuben De Man, Zhongyu Cai, Pramath Doddaballapur, et al.
Aob PLANTS|October 23, 2019
Drivers of the relative richness of naturalized and invasive plant species on EarthFranz Essl, Wayne Dawson, Holger Kreft, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
Cancer|August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b studyMohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
Pageof 61